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Recently, we reported that the type 6 secretion system (T6SS) of Aeromonas hydrophila SSU
plays an important role in bacterial virulence in a mouse model, and immunization of animals with
the T6SS effector haemolysin co-regulated protein (Hcp) protected them against lethal infections
with wild-type bacteria. Additionally, we showed that the mutant bacteria deleted for the vasH
gene within the T6SS gene cluster did not express the hcp gene, while the vasK mutant could
express and translocate Hcp, but was unable to secrete it into the extracellular milieu. Both of
these A. hydrophila SSU mutants were readily phagocytosed by murine macrophages, pointing to
the possible role of the secreted form of Hcp in the evasion of the host innate immunity. By using
the DvasH mutant of A. hydrophila, our in vitro data showed that the addition of exogenous
recombinant Hcp (rHcp) reduced bacterial uptake by macrophages. These results were
substantiated by increased bacterial virulence when rHcp was added along with the DvasH
mutant in a septicaemic mouse model of infection. Analysis of the cytokine profiling in the
intraperitoneal lavage as well as activation of host cells after 4 h of infection with the DvasH
mutant supplemented with rHcp indicated that this T6SS effector inhibited production of pro-
inflammatory cytokines and induced immunosuppressive cytokines, such as interleukin-10 and
transforming growth factor-b, which could circumvent macrophage activation and maturation. This
mechanism of innate immune evasion by Hcp possibly inhibited the recruitment of cellular immune
components, which allowed bacterial multiplication and dissemination in animals, thereby leading
to their mortality.
INTRODUCTION
Aeromonas hydrophila is among the most common species
associated with wound and soft tissue infections, gastro-
enteritis and septicaemia in the host (Chopra & Houston,
1999; Janda & Abbott, 1998). Our laboratory group and
others have characterized several virulence factors from
Aeromonas species, which are secreted via the type 2 and
type 3 secretion systems (Carvalho-Castro et al., 2010;
Chopra et al., 2000; Sha et al., 2005, 2007; Sierra et al.,
2007; Tan et al., 2008; Vilches et al., 2009). Our most recent
studies are focused on the type 6 secretion system (T6SS)
and its effectors from diarrhoeal isolate SSU of A.
hydrophila (Suarez et al., 2008, 2010). Although the T6SS
is highly conserved in Proteobacteria, the general mech-
anism as to how this system operates remains poorly
understood (Das & Chaudhuri, 2003).
A. hydrophila SSU has one chromosomally located T6SS
gene cluster which is regulated by the s
54 activator encoded
by the virulence-associated gene, vasH (Suarez et al., 2008).
We reported that the DvasH mutant of A. hydrophila SSU
was unable to express genes encoding haemolysin-coregu-
lated protein (Hcp) and the valine glycine repeat G (VgrG)
family of proteins VgrG2 and VgrG3, which constitute part
of the T6SS gene cluster (Suarez et al., 2008). However, this
mutant was able to express, but was unable to secrete or
translocate, VgrG1 that resides outside of the T6SS gene
cluster (Suarez et al., 2010). Further, deletion of hcp or
vgrG prevents secretion of the other, thereby demonstrat-
ing dual roles of Hcp and VgrG as structural components
of the T6SS apparatus and as effector proteins (Cascales,
Abbreviations: 7-AAD, 7-amino actinomycin D; DC, dendritic cell;
G-CSF, granulocyte colony-stimulating factor; IFN, interferon; IL,
interleukin; i.p., intraperitoneal; KC, keratinocyte-derived chemokine;
LPS, lipopolysaccharide; M-CSF, macrophage colony-stimulating factor;
MHC, major histocompatibility complex; MIP, macrophage inflammatory
protein; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium
bromide; SOCS, suppressor of cytokine signalling; T6SS, type 6
secretion system; TGF, transforming growth factor; Th, T helper [cell];
TNF, tumour necrosis factor; WT, wild-type.
A supplementary figure, showing the effect of Hcp and rHcp on bacterial
growth and murine macrophages, is available with the online version of
this paper.
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hallmark of the T6SS secreted proteins in all of the bacteria
that possess this system (Bingle et al., 2008; Cascales, 2008;
Filloux et al., 2008; Pukatzki et al., 2009). Although the role
of VgrG1 in bacterial virulence was convincingly demon-
strated recently by us in A. hydrophila SSU (Suarez et al.,
2010) and V. cholerae (Ma et al., 2009; Ma & Mekalanos,
2010), the mechanism of Hcp in modulating the organism’s
virulence is poorly understood.
Innate immunity is the first line of host defence against the
challengedorganisms, andpattern recognition receptorssense
different microbial ligands (known as pathogen-associated
molecular patterns, PAMPs) (Barton & Medzhitov, 2003;
Janeway & Medzhitov, 2002; Medzhitov & Janeway, 1999;
Taylor et al., 2005), resulting in the triggering of signalling
cascades that determine the host immune response by
modulating maturation, activation and recruitment of
cellular effectors [e.g. neutrophils, macrophages, dendritic
cells (DCs) and natural killer cells] (Henneke & Golenbock,
2004; Hume, 2006; Medzhitov & Janeway, 1999; Plu ¨ddemann
et al., 2006).
Phagocytosis is crucialforboth innate and adaptive immunity
(Coombes et al., 2004; Henneke & Golenbock, 2004;
Medzhitov & Janeway, 1999), and macrophages and DCs
are professional antigen-presenting cells which act as tissue
sentinels and are able to present antigens to naı ¨ve T-cells
(Gordon & Taylor, 2005; Hume, 2006, 2008). Bacteria have
developed different mechanisms to avoid innate immunity
ranging from their ability to avoid recognition by toll-like
receptor-4 (Ernst et al., 1999; Hajjar et al., 2002; Kawasaki
et al., 2004), altering antigenicity of surface molecules to avoid
phagocytosis (Seifert, 1996), interfering with mitogen-acti-
vated protein kinase signalling cascades (Park et al., 2002;
Sweet et al., 2007; Thiefes et al.,2 0 0 6 ) ,m o d u l a t i n ga c t i n
polymerization and apoptosis (Abrahams & Hensel, 2006;
Pujol & Bliska, 2005; Ruckdeschel et al., 2002; Viboud &
Bliska, 2005), manipulating phagosome trafficking and
maturation (Dramsi & Cossart, 2002; Sturgill-Koszycki et al.,
1994; Uchiya et al., 1999), and inducing the production of
immunosuppressive cytokines, particularly interleukin (IL)-
10. The latter mechanism avoids activation of macrophages,
maturation of DCs and recruitment of granulocytes
(McGuirk et al., 2002; Sing et al., 2002; Zuany-Amorim
et al., 2002).
Previously, we demonstrated that A. hydrophila SSU DvasH
and DvasK mutants were easily phagocytosed by murine
RAW 264.7 macrophages compared with the phagocytosis
of wild-type (WT) bacteria (Suarez et al., 2008). Further,
we showed that the DvasH mutant strain did not express
the gene encoding Hcp and that the DvasK mutant was able
to produce Hcp, but was unable to secrete it (Suarez et al.,
2008). Hence, we hypothesized that the secreted form of
Hcp could be playing a role in inhibition of phagocytosis of
A. hydrophila SSU by macrophages. Here, we report that
Hcp indeed played a role in modulating the innate
immunity by inhibiting the phagocytosis of A. hydrophila
SSU, thus allowing its multiplication and spread to
different organs of the host. Our results show that Hcp is
able to bind to macrophages and induce the production of
IL-10 and transforming growth factor (TGF)-b, affecting
the activation and maturation of macrophages, and,
consequently, the recruitment of other cellular immune
components needed to clear bacterial infection.
METHODS
Cell line and bacterial strains. RAW 264.7, a murine macrophage
cell line, was maintained in Dulbecco’s modified eagle medium with
high glucose (DMEM) (Invitrogen), supplemented with 10% fetal
bovine serum (FBS) under standard cell culture growth conditions.
A. hydrophila SSU Dact (act encodes the type 2 secretion system-secreted
cytotoxic enterotoxin) (Xu et al., 1998) and Dact/DvasH isogenic mutant
strains were developed in the laboratory as described previously (Suarez
et al., 2008). These mutants were grown in LB medium supplemented
with kanamycin (50 mgm l
21)f o rA. hydrophila Dact, and kanamycin,
streptomycin (40 mgm l
21) and spectinomycin (50 mgm l
21) for the A.
hydrophila Dact/DvasH mutant.
Recombinant Hcp protein. The hcp (hcp2 residing within the T6SS
cluster) gene was cloned in the pET-30a vector for the production of
recombinant protein as reported previously (Suarez et al., 2008). rHcp
containing a 66 His tag was purified by nickel affinity chromato-
graphy, dialysed against PBS, and then passed through a polymyxin
column (Bio-Rad) to remove any residual lipopolysaccharide (LPS).
The pass-through fraction was filtered by using a 0.2 mm filter, and the
protein concentration was quantified by using the Bradford assay (Bio-
Rad). The removal of LPS from rHcp was verified by the Limulus
amebocyte lysate assay (Pyrosate-Dial Medical Supply), and the purity
of rHcp was verified by Coomassie Blue staining of the gel.
Cell viability. To determinehost cellviability(RAW264.7cells treated
with 10 mg rHcp ml
21 for different time periods), we performed the 7-
amino actinomycin D (7-AAD) (Becton Dickinson) and the colori-
metric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide
(MTT) (Chemicon) assays, as described previously (Sierra et al., 2007).
Conditioned medium. To obtain conditioned medium containing
Hcp, we grew the Dact mutant strain of A. hydrophila SSU (1610
7
c.f.u.) in 3 ml DMEM supplemented with 0.5% FBS at 37 uC. After
2 h, the bacteria were removed by centrifugation, and the supernatant
was passed through a 0.2 mm membrane filter. The resulting medium
was tested by Western blot analysis for the presence of Hcp by using
specific antibodies, and used immediately in the phagocytosis assay.
Western blot analysis. Westernblot analysiswasperformedtodetect
Hcp in the conditioned medium collected after infection of RAW 264.7
cells with various strains of A. hydrophila. Briefly, tissue culture
supernatant was filtered by using a 0.2 mm filter to remove bacteria;
proteins in the supernatant were separated by using 15% SDS-PAGE.
The proteins were then transferred to a nitrocellulose membrane which
was blocked with 5% skimmed milk+1% BSA overnight at 4 uC.
Mouse–anti-Hcp serum was used at a dilution of 1:2000 for 1 h, and
horseradish peroxidase-conjugated, goat–anti-mouse antibodies were
used at a dilution of 1:5000 for 45 min. The blot was then developed
by using ECL-Western blotting detection reagent (GE Healthcare).
Phagocytosis assay. Briefly, 1.5610
6 RAW 264.7 cells suspended
in 1 ml DMEM supplemented with 0.5% FBS were split into aliquots
in polypropylene tubes (12675 mm). Different bacterial strains were
added at an m.o.i. of 10 for 30 min. Then, the cell suspension was
T6SS and bacterial virulence
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pellet was resuspended in 500 ml of DMEM plus 0.5 % FBS (above)
and 250 mg gentamicin ml
21 (CellGro) to kill extracellular bacteria.
After 2 h, the macrophages were washed three times with 1 ml
DMEM to remove dead bacteria and gentamicin. The host cells were
lysed in 500 ml sterile water, and the cell lysates were plated on LB
agar plates containing kanamycin (50 mgm l
21) to determine c.f.u.
(Suarez et al., 2008). We examined complete lysis of the host cells
under the microscope before plating the cell lysates.
Animal survival. Groups of 10 Swiss Webster female mice (Charles
River) were challenged via the intraperitoneal (i.p.) route with a
sublethal dose of A. hydrophila Dact/DvasH mutant, either alone or in
combination with different amounts of rHcp (1–10 mg). As a control,
a group of mice was challenged with either the highest dose of rHcp
(10 mg) or the Dact parental strain. The survival of mice was followed
for 16 days post-infection.
Bacterial spread. Mice were infected via the i.p. route with a
sublethal dose of A. hydrophila Dact/DvasH mutant alone or in
combination with rHcp (10 mg). The animals were euthanized after
48 h, and sections of liver, spleen and lungs were homogenized and
used to determine bacterial burden (Agar et al., 2009).
Intraperitoneal lavage. After4 hofchallengeofmiceviathei.p.route
with a sublethal dose of A. hydrophila Dact/DvasH mutant alone or in
combination withrHcp,the animals were euthanized, andthe peritoneal
cavity was flushed with 1.5 ml sterile Hanks’ solution (Invitrogen). The
lavage was collected and centrifuged at 250 g for 5 min. The supernatant
was used for evaluating various cytokines/chemokines by the multiplex
bead array, and the pellets containing host cells were used to determine
their phenotypes by flow cytometry (see below).
Hcp-binding assay. The whole cell population from the intraper-
itoneal lavage of mice was incubated with rHcp (10 mgm l
21) for 1 h.
Then, the cells were incubated for 30 min with anti-mouse CD16/
CD32 antibodies (Becton Dickinson). Next, the cells were dispensed
into different tubes and incubated with pre-immune mouse serum
(1:100) as an isotype control, or with the mouse anti-Hcp serum
(1:100) for 1 h. Subsequently, the host cells were incubated with Alexa
Fluor 488-conjugated goat anti-mouse antibodies (Invitrogen) for
45 min, followed by incubations with PE-Cy5-conjugated anti-mouse
F4/80, PE-conjugated anti-mouse Gr-1 antibodies, and their respective
isotypecontrols. Betweensteps, the cells were washed twice with chilled
Hanks’ solution, and all the incubations were performed on ice. The
cells were acquired in a FACScanto (Becton Dickinson) flow cytometer
and analysed by using FACSDiva software (Becton Dickinson).
Quantification of Hcp produced by the Dact mutant of A.
hydrophila SSU. To determine the amount of Hcp produced by the
parental A. hydrophila strain in the mouse peritoneum after 4 h of
infection, we infected animals via the i.p. route with 3610
7 bacterial
cells per animal. Subsequently, the animals were euthanized and the
intraperitoneal cavity was flushed with 3 ml Hanks’ solution. This
lavage was filtered by using 0.2 mm membrane filters and precipitated
with 10% (final concentration) TCA. The protein pellet was
resuspended in 500 ml SDS loading buffer, and 20 ml was separated
by using 6–15% SDS-PAGE. In parallel, different concentrations of
rHcp were loaded on a similar gel to build a standard curve. Proteins
from both the gels were transferred to nitrocellulose membranes, and
Western blot analysis was performed using anti-rHcp antibodies. X-
ray films obtained after exposure of the membranes were analysed by
densitometry, and the concentration of Hcp present in the
intraperitoneal lavage was determined from the standard curve.
Cytokines. The supernatants obtained after intraperitoneal lavages of
mice (see Intraperitoneal lavage) were tested for cytokine/chemokine
levels by a multiplex bead array (Millipore) following the manufac-
turer’s instructions. The data were acquired and analysed in a Bioplex
200 system which uses Bioplex manager software v.5.0 (Bio-Rad).
We measured levels of TGF-b in the intraperitoneal lavage
supernatant samples by using an ELISA (eBiosciences) and following
the manufacturer’s instructions. The colour reaction was read in a
microplate reader Versa-max (Molecular Devices).
Flow cytometry. Cell pellets collected after intraperitoneal lavages of
mice (see Intraperitoneal lavage) were stained with a panel of
antibodies conjugated with FITC (anti-CD11c, anti-CD69), PE (anti-
Gr-1, anti-MHC-class II) and PE-Cy5 (anti-F4/80) for flow cytometry
(eBiosciences). The cells were incubated with antibodies for 1 h and
then washed twice with 1 ml PBS and fixed with 2% paraformalde-
hyde. The cells were acquired in a FACScan and analysed by
FACSdiva software (Becton Dickinson). Prior to incubation with
antibodies, receptors Fcc III/II were blocked using anti-CD16/CD32
antibodies (BD Pharmingen) for 30 min.
Statistical analysis. The data were analysed by one-way ANOVA
and Tukey’s post-test with GraphPad Prism version 4 software, and
the animal survival curves were analysed by the Logrank test. At least
three independent experiments were performed to represent bio-
logical replicates, unless otherwise stated.
RESULTS
Hcp inhibits the phagocytosis of A. hydrophila
SSU Dact/DvasH mutant in vitro
Since the secretion of Hcp was affected in both the DvasH
and DvasK mutant strains (Suarez et al., 2008), we
hypothesized that the secreted form of Hcp could be playing
a role in the bacterial inhibition of phagocytosis. To test this,
we used conditioned medium from the Dact parental strain
of A. hydrophila which contained Hcp (Fig. 1a) in the
phagocytosis assay. Consequently, RAW 264.7 murine
macrophages were infected with the Dact/DvasH mutant in
the conditionedmedium,thus allowingcomplementationof
the mutant with exogenous Hcp protein. We noted that the
ability of the A. hydrophila Dact/DvasH mutant to be
phagocytosed by macrophages was reduced in the presence
of Hcp (Fig. 1b). To confirm that this effect was indeed due
to Hcp and not to other secreted bacterial proteins, we
performed a phagocytosis assay by using the Dact/DvasH
mutant in conjunction with different concentrations of
purified rHcp. We found that phagocytosis of the mutant by
macrophages was inhibited by rHcp in a dose-dependent
fashion, with statistically significant differences observed at
rHcp doses of 5.6 mg and greater (Fig. 1c) compared with
mutant bacteria (Dact/DvasH) alone without rHcp.
To determine whether the doses of rHcp necessary to
inhibit phagocytosis in our in vitro experiments were
physiologically relevant, we measured the amounts of Hcp
produced by the parental Dact mutant strain of A.
hydrophila in the mouse peritoneum and we found 8–
10 mg Hcp after 4 h of infection, indicating physiological
relevance of the rHcp doses used in this study (Fig. 1c).
Our positive and negative controls in this assay included
macrophages infected with the Dact and Dact/DvasH strains
G. Suarez and others
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showed minimal phagocytosis, while the latter exhibited
much higher levels of phagocytosis by macrophages. These
data clearly indicate that the secreted Hcp plays a role in
bacterial phagocytosis. We confirmed that the difference in
phagocytosis between the parental Dact strain of A.
hydrophila and that of the Dact/DvasH mutant was not
due to differences in their growth rates (Supplementary
Fig. S1a, available with the online version of this paper) or
to toxic effects of rHcp on RAW 264.7 cells for at least up
to 6 h, as determined by MTT and 7-AAD assays
(Supplementary Fig. S1b, c), and as well as by microscopic
visualization of host cells (data not shown). The purity of
rHcp was evaluated by Coomassie-Blue-staining of the gel
(Fig. 1c, inset). In addition, we tested rHcp for any residual
LPS and found less than 1 endotoxin unit in 10 mg of the
recombinant protein, which has no influence on macro-
phage activation.
Hcp decreases the survival rate of mice infected
with the Dact/DvasH mutant of A. hydrophila SSU
Since the secreted form of Hcp decreased bacterial
phagocytosis, and we showed earlier that mice infected
via the i.p. route with the DvasH mutant had a better
survival rate compared with mice infected with the WT
strain (Suarez et al., 2008), we hypothesized that bacteria
producing Hcp would have a better chance of evading the
innate immunity and causing systemic effects. Hence, we
challenged mice with a sublethal dose of the Dact/DvasH
mutant together with rHcp at different concentrations and
monitored deaths for 16 days. We found that the addition
of rHcp decreased the survival rates of mice after infection
with the Dact/DvasH mutant, with 100% of the mice dying
with 5 and 10 mg of rHcp (Fig. 2). These data indicated
complementation of the above mutant with exogenous
rHcp in terms of bacterial virulence.
Hcp enhances the spread of the Dact/DvasH
mutant of A. hydrophila SSU in a mouse model
Since our data showed that the presence of rHcp increased
the death rate of mice infected with sublethal doses of the
Dact/DvasH mutant, we evaluated the bacterial load in
mouse organs after 48 h of infection in the presence of
rHcp. Our results indicated that rHcp allowed the mutant
bacteria to spread more efficiently to different organs
(lungs, livers and spleens) possibly resulting in the animals’
death due to a systemic effect (Fig. 3). These bacterial
numbers in different organs of mice infected with the Dact/
DvasH mutant in the presence of rHcp were very similar to
their numbers reported recently from mouse organs after
infection with the Dact parental strain of A. hydrophila
(Sierra et al., 2010). Our results supported the prediction
that Hcp played a role in innate immunity by avoiding
bacterial clearance in the peritoneal cavity by phagocytosis,
thus allowing organisms to multiply and spread to various
organs.
Fig. 1. Hcp inhibits phagocytosis of the Dact/DvasH mutant of A.
hydrophila SSU by RAW 264.7 murine macrophages. (a) Western
blot analysis of the conditioned medium from the parental Dact
strain of A. hydrophila by using antibodies to Hcp. The presence of
a doublet on the Western blot may represent the degradation
product of Hcp. (b) Conditioned medium containing Hcp inhibits
phagocytosis of the Dact/DvasH mutant. Phagocytosis assay using
the A. hydrophila Dact/DvasH mutant and RAW 264.7 cells was
performed in conditioned medium from A. hydrophila SSU Dact
parental strain as the exogenous source of Hcp (mid-grey). We also
used conditionedmedium from A. hydrophila Dact/DvasH mutant as
a control for any other secreted proteins/factors independent of the
T6SS that could affect phagocytosis (dark grey). Another control
included fresh DMEM supplemented with 0.5% FBS (light grey).
Data shown are the mean±SD of three independent experiments.
(c) rHcp inhibits phagocytosis of the A. hydrophila Dact/DvasH
mutant. As a control, we included A. hydrophila Dact/DvasH mutant
without rHcp, as well as the A. hydrophila Dact parental strain. Data
shown are the mean±SD of three independent experiments. The
statistical difference was calculated by a one-way ANOVA test.
*P,0.05; **P,0.01. The Coomassie Blue stained gel (inset) shows
the purity of rHcp obtained after purification and removal of LPS.
The lanes were loaded with5 mg (lane 1) and 10 mg (lane 2) of
rHcp. The physiological amount of Hcp produced by the parental
strain of A. hydrophila was up to 8–10 mg in the peritoneum after
infection.
T6SS and bacterial virulence
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Our earlier study showed that Hcp present in the
conditioned medium of the WT strain of A. hydrophila
SSU was able to bind RAW 264.7 macrophages (Suarez
et al., 2008). To confirm that Hcp also binds to primary
macrophages, we collected whole cell populations from the
peritoneal cavity of naı ¨ve mice and, after incubating them
with rHcp ex vivo, we performed a multicoloured flow
cytometry analysis by using antibodies against Hcp, F4/80
and Gr-1. Fig. 4(a) shows the forward scatter versus the
side scatter plot from the whole cell population isolated
after the lavage. For analysis, we evaluated rHcp binding to
cells gated on F4/80 (macrophages) (Fig. 4b) and on Gr-1
(granulocytes) (Fig. 4c). As can be seen, rHcp was able to
bind macrophages (Fig. 4d) and granulocytes (Fig. 4e),
although the differential shift of the curve for granulocytes
indicated that rHcp binding to this particular cell type was
much less compared with its isotype control and that for
the macrophages.
Hcp modulates the expression of activation
markers on intraperitoneal immune cells
Since our data indicated that rHcp binds to cells involved
in the innate immune response, we analysed, by flow
cytometry, the status of these cells after 4 h of infection
with the Dact/DvasH mutant of A. hydrophila given along
with two different doses of rHcp. Specifically, we analysed
changes in the percentage of macrophages (F4/80),
granulocytes (Gr-1) and DCs (CD11c). In addition, we
examined the expression of CD69 (an early activation
marker) and the major histocompatibility complex (MHC)
class II. As controls, we used lavages from uninfected
(given only PBS) mice, infected with the Dact/DvasH
mutant of A. hydrophila alone along with PBS, and injected
via the i.p. route with rHcp alone.
We noted a significant increase in the percentage of Gr-1-
positive cells in the peritoneal cavity of animals infected
with the Dact/DvasH mutant when compared with the
uninfected mice (Fig. 5a). However, this difference was
independent of the presence of rHcp. Additionally, our
results showed no significant changes in the percentage of
macrophages and DCs in the peritoneal cavity after 4 h of
infection, although we noted marginal increases in CD11c-
positive cells (not statistically significant) related to the
increasing concentrations of rHcp (Fig. 5a).
We then analysed the expression of CD69 and MHC class
II in the total cell population as well as in cells gated for F4/
80, Gr-1 and CD11c after cells were infected with the Dact/
DvasH mutant and given rHcp. As shown in Fig. 5(b), the
percentage of CD69 in F4/80- and Gr-1-positive cells
Fig. 2. rHcp increases the virulence of the A.
hydrophila SSU Dact/DvasH mutant. Survival
curves of mice (n510) infected via the i.p.
route with 810
6 c.f.u. of A. hydrophila Dact/
DvasH mutant in the presence of different
concentrations of rHcp. As a control, groups of
mice (n510) were infected with the same
doses of the mutant bacteria without rHcp or
the Dact parental strain. As another control for
rHcp toxicity, mice were inoculated with the
highest concentration of rHcp without the
bacteria. The deaths were recorded for
16 days after infection. Asterisks represent
groups of mice with statistically significant
differences in mortality against the same doses
of bacteria without the rHcp, P,0.05. Each
animal experiment was performed in duplicate
and a representative experiment is shown.
Fig. 3. rHcp plays a role in the spread of A. hydrophila SSU Dact/
DvasH mutant to different mouse organs. Bacterial burden was
measured in the lungs, livers and spleens 48 h after i.p. infection
with 310
7 c.f.u. A. hydrophila Dact/DvasH mutant in the presence
of rHcp (10 mg) (mid-grey). Mice infected with the same dose of
bacteria without rHcp were used as a control (light grey). The data
were normalized with the organ weights. The graph represents
data from 10 mice per group. Error bars show SD.
G. Suarez and others
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of rHcp used. Likewise, the percentage of MHC class II-
positivecellsinF4/80cellsdecreasedaftermicewereinfected
with the Dact/DvasH mutant and given the higher dose of
rHcp. However, the expression of MHC-class II showed an
increase in CD11c cells (with 10 mg rHcp), although the data
were not statistically significant (Fig. 5c). Likewise, injection
of rHcp alone did not significantly change the percentage of
CD69 and MHC class II in any of the cell types analysed
compared with the uninfected group of mice.
Hcp modifies cytokine/chemokine production
profiles induced by the A. hydrophila SSU Dact/
DvasH mutant
Since rHcp modulates the expression of activation markers
on macrophages, granulocytes and DCs, we analysed
cytokine/chemokine patterns induced by the Dact/DvasH
mutantintheperitonealcavityafter4 hofinfection(Table1
andFig.6).We found that infectionofmicewith themutant
induced the production of a wide range of pro- and anti-
inflammatory cytokines/chemokines and growth factors.
However, the addition of rHcp, along with the Dact/DvasH
mutant, during infection significantly modified the levels of
some of these cytokines/chemokines. Thus, the concentra-
tions of IL-2, IL-10, IL-15, IL-12p70, macrophage inflam-
matory protein (MIP)-1b, MIP-2, granulocyte colony-
stimulating factor (G-CSF), IL-6, and keratinocyte-derived
chemokine (KC) were increased by adding rHcp; however,
the production of gamma interferon (IFN-c), IL-1a and
macrophage colony-stimulating factor (M-CSF) was inhib-
ited (Table 1 and Fig. 6). On the other hand, intraperitoneal
lavages from mice injected with rHcp alone showed low or
non-detectable levels of cytokines/chemokines (Table 1).
Hcp induces an alternative pathway of
macrophage activation
Activation of macrophages is an important mechanism in
innate immunity against foreign invading organisms. There
are two types of macrophage activation. M1 or classical
activation is mainly a pro-inflammatory or T helper (Th)1-
like response focused on removal and clearing of the
infection or debris produced by an injury, and M2 or
Fig. 4. rHcp binds to intraperitoneal immune cells. Total intraperitoneal cells were recovered after peritoneal lavages and
incubated with rHcp (10 mg) ex vivo. Subsequently, the cells were stained by using antibodies against Hcp (FITC), Gr-1 (PE)
and F4/80 (PE-Cy5). (a) Side scatter versus forward scatter plot for the total intraperitoneal cells. (b) Side scatter versus F4/80
PE-Cy5 plot from the total cell population gated for the F4/80 positive cells (red). (c) Side scatter versus Gr-1 PE plot from the
total cell population gated for the Gr-1-positive cells (blue). (d) A histogram plot showing staining for Hcp (Alexa Fluor 488) in
cells which were F4/80 positive. The empty curve represents the isotype control, while the filled curve (red) represents cells
incubated with anti-Hcp antibodies. (e) A histogram plot showing staining for Hcp (Alexa Fluor 488) in cells that were Gr-1
positive. The empty curve represents the isotype control and the filled curve (blue) represents cells incubated with anti-Hcp
antibodies.
T6SS and bacterial virulence
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and wound healing. The latter is characterized by a low
infiltration of cellular components and a Th2-like cytokine
phenotype. Our data indicated that the presence of rHcp
during infection with the Dact/DvasH mutant could
modulate an alternative pathway of macrophage activation,
which is supported by decreases in some pro-inflammatory
cytokine levels, such as IFN-c and IL-1a, and increases in
anti-inflammatory cytokines, such as TGF-b, IL-6, IL-9 and
IL-10 (Table 1 and Fig. 6). These results were also
supported by the low levels of M-CSF and tumour necrosis
factor (TNF)-a induced by infection with the Dact/DvasH
mutant in mice, which remained unaltered in the presence
of rHcp (Table 1 and Fig. 6). Taken together, these results
correlated with the minimal macrophage recruitment in
the peritoneal cavity of mice after infection with the Dact/
DvasH mutant of A. hydrophila SSU (Fig. 5a, F4/80 panel).
DISCUSSION
In this report, we described the role of the secreted form of
Hcp in modulating the innate host immune response,
specifically by inhibiting phagocytosis by macrophages. It
has been reported that some bacterial proteins are able to
interfere with phagocytosis by inducing host cell apoptosis,
especially via caspase-1 activation (Abrahams & Hensel,
2006; Diacovich & Gorvel, 2010). We also showed that
episomal expression of the hcp gene in epithelial cells
induced apoptosis (Suarez et al., 2008); however, there are
no available data to show whether extracellular Hcp has
any effect on the viability of eukaryotic cells. Based on 7-
AAD and MTT assays, we did not detect any significant
toxicity in macrophages which could be associated with
rHcp until up to 24 h of incubation, except for a small
increase in mitochondrial activity (measured by MTT)
detected after 2 h of incubation. We believe this initial
increase was due to the activation of macrophages by rHcp.
Also, we found an increase in the percentage of 7-AAD-
positive cells (~6% of the total population) as well as a
decrease in the mitochondrial activity at 24 h that could be
related to cell death after stimulation with rHcp. Since our
experiments did not require incubation times longer than
4 h, we consider that the inhibition of phagocytosis in vitro
due to Hcp present in the medium was independent of any
toxic effects of Hcp on macrophages. Additionally, growth
curves of the A. hydrophila Dact and Dact/DvasH mutant
strains were similar, indicating that differences in phagocy-
tosisoftheA.hydrophila Dact/DvasHmutantcomparedwith
that of its parental strain were not related to any differences
in growth rates caused by the deletion of the vasH gene.
There are several examples of bacterial proteins that target
phagocytosis at different levels in order to establish an
infection. Our results showed that the secretion of Hcp into
the extracellular medium played an important role in
inhibiting innate immunity mediated by macrophages in
vitro. Similarly, the presence of rHcp during infection
increased bacterial virulence and allowed bacterial spread
to different mouse organs after infection with the A.
hydrophila Dact/DvasH mutant. These data indicated that
the increased virulence of this mutant in the presence of
Hcp was associated with the inhibition of phagocytosis.
Macrophages, immature DCs and granulocytes are the main
components of innate immunity and the first line of defence
against invading organisms. Previously, we reported that the
secreted form of Hcp binds RAW 264.7 macrophages
(Suarez et al., 2008). In this report, we extended this
observation and tested the binding of rHcp to primary
intraperitoneal cells. We found that rHcp bound mainly to
macrophages, although some binding to granulocytes was
Fig. 5. rHcp modulates the levels of activation
markers on intraperitoneal innate immune cells
of mice. Flow cytometric analysis of intraper-
itoneal cells recovered from lavages 4 h after
infection with 310
7 c.f.u. A. hydrophila SSU
Dact/DvasH mutant in the presence of different
doses of rHcp (1 and 10 mg). The PBS group
represents animals challenged with only bac-
teria and PBS in place of rHcp. (a) Percentage
of positive cells for F4/80 (macrophages), Gr-
1 (granulocytes) and CD11c (DCs). (b) and (c)
Percentage of positive cells expressing CD69
(b) and MHC class II (c) for the total population
or for cells gated for F4/80, Gr-1 or CD11c.
Statistically significant differences were mea-
sured by the one-way ANOVA test followed by
Tukey’s test. *P,0.05; **P,0.01. Error bars
indicate SD.
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between macrophages and granulocytes could be related to
differences in the Hcp-binding receptor(s) on these two cell
types. Additionally, we tested binding of rHcp to human
epithelial cell lines, such as HT-29 and HeLa. We found that
rHcp bound to HeLa and HT-29 cells at levels that were five
and nine times lower, respectively, compared with RAW
cells (data not shown). Together, these data suggest that
macrophages are the major cell target for Hcp.
Analysis of cytokine/chemokine levels in peritoneal lavages
showed increases, dependent on the dose of rHcp used, in
those involved in granulocyte/neutrophil recruitment and
maturation, such as G-CSF, KC and MIP-2. These data
may suggest that Hcp does not affect the recruitment of
granulocytes in the peritoneal cavity of mice after infection
with the Dact/DvasH mutant; however, reduction in CD69
levels on the surface of granulocytes in an rHcp dose-
dependent manner indicates that this T6SS effector could
have an effect on granulocyte activation.
The percentage of DCs (CD11c) was somewhat increased
in mice infected with the Dact/DvasH mutant in the
presence of rHcp. Importantly, these cells also showed
Table 1. Cytokine/chemokine levels in the peritoneal lavages of mice
Concentrations are in pg ml
21; mean±SD. ND, Not detected.
Cytokine/chemokine* A. hydrophila SSU Dact/DvasH mutant rHcp (10 mg)
+ PBS + rHcp (10 mg)
Eotaxin 1018±58 1088±35 120±38
G-CSF 126849±18670 184895±11335D 434±108
GM-CSF 128±12 142±24 13±2
IFN-c 414±70 183±39§ ND
IL-1a 276±11 240±14D 18±5
IL-1b 811±68 872±90 ND
IL-2 12±32 7 ±12d ND
IL-3 ND ND ND
IL-4 ND ND ND
IL-5 129±22 100±18 ND
IL-6 62608±11044 118731±22410D 398±105
IL-7 ND ND ND
IL-9 141±11 209±6d 49±5
IL-10 109±32 192±32D ND
IL-12p40 ND ND ND
IL-12p70 123±3 133±3D 8±2
IL-13 ND ND ND
IL-15 14±12 0 ±0.5§ ND
IL-17 1332±112 1774±259 ND
IP-10 413±33 395±19 198±73
KC 19104±4320 36500±6353D 47±27
LIF ND ND ND
LIX 560±55 568±11 38±10
MCP-1 16108±1562 17860±711 200±73
M-CSF 12±27 ±2d ND
MIG 2180±173 1919±96 55±23
MIP-1a 401±29 481±18 86±7
MIP-1b 526±76 734±61D 60±17
MIP-2 6288±935 10754±633D 20±5
RANTES 207±15 238±17 14±3
TNF-a 16±22 2 ±3 ND
VEGF ND ND ND
*GM-CSF, granulocyte-macrophage colony-stimulating factor; LIF, leukaemia inhibitory factor; LIX, LPX-
inducible CXC chemokine; MCP, monocyte-chemoattractant protein; MIG, monocyte induced by IFN-c;
VEGF, vascular endothelial growth factor.
DP,0.05 compared with + PBS.
dP,0.01 compared with + PBS.
§P,0.001 compared with + PBS.
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the percentage of the MHC class II molecules in the
presence of rHcp. These results led us to suggest that Hcp
might be inducing the maturation of DCs (CD11c
+/ MHC
class II
+); nonetheless, low levels of IL-12p70 and IFN-c,
and induction of IL-10 by rHcp in mice infected with the
Dact/DvasH mutant would hamper their normal activation
and induction of regulatory phenotypes.
Macrophage activation is an important step in the
modulation of immune responses, and a subdivision of
alternative activation (M2) called ‘deactivation’ is mediated
by the production of immunosuppressive cytokines IL-10
and TGF-b, downregulation of MHC class II molecules and
pro-inflammatory cytokines/chemokines, low levels of IL-4
andIL-13production,andfinally lowlevelsof productionof
reactive oxygen and nitrogen intermediates (Gordon, 2003;
Hornef et al., 2002; Moore et al., 1993). This kind of
activation could predispose the host to infection by the
induction of regulatory cells which are inhibitors of
inflammation, even in the presence of inflammatory
cytokines/chemokines (Gordon & Taylor, 2005; Mantovani
et al., 2004; Mosser, 2003; Mosser & Edwards, 2008). In
accordance, we found that the pattern of cytokines/
chemokines in the peritoneal cavity after 4 h of infection
with the A. hydrophila Dact/DvasH mutant in the presence of
rHcp, was indicative of an alternative pathway of activation
or ‘deactivation’ of macrophages led by the production of
IL-10 and TGF-b, decreases in IFN-c, low levels of TNF-a,
and no detection of IL-4 and IL-13.
IL-6 is an important modulator of the immune response
due to its dual role as a Th1 cytokine, inducing the
recruitment of cellular components, or as a Th2 cytokine,
inhibiting the production of IFN-c and enhancing the
production of IL-10 by induction of suppressor of cytokine
signalling (SOCS) proteins (Diehl & Rincon, 2002; Dong
et al., 2009). In our study, we found that the Dact/DvasH
mutant induced the secretion of high levels of IL-6 in the
intraperitoneal cavity, which was even higher when rHcp
was present. We believe that IL-6 together with IL-10 and
TGF-b, and low levels of IFN-c and TNF-a, has a role in the
differentiation of immune cells present in the peritoneal
cavity by induction of SOCS-1 and -3. The SOCS family of
regulators are involved in the suppression of nuclear
factor-kB signalling pathways, as well as in promoting IL-
10 production (Dong et al., 2009). On the other hand,
TGF-b, IL-9 and IL-10 also promote the production of
SOCS proteins, which have been associated with impaired
production of TNF-a, downregulation of nitric oxide
synthase, and the expression of the IL-1ra antagonist gene
(Berlato et al., 2002; Lejeune et al., 2001).
We previously reported that immunization of mice with
rHcp conferred protection against future infections with
lethal doses of WT A. hydrophila SSU (Suarez et al., 2008).
Overall, the results reported in this study highlighted the
importance of Hcp in early stages of A. hydrophila
infection. Therefore, adaptive immunity mediated by
antibodies could neutralize the effect that Hcp has on
inhibition of phagocytosis and, thus, enhance bacterial
clearing by opsonization-mediated phagocytosis.
We also have characterized other A. hydrophila SSU toxins
with enzymic activities that could impair phagocytosis. For
example, VgrG1, a T6SS effector protein, has actin-ADP-
ribosylation activity (Suarez et al., 2010), and the type 3
secretion system effector protein AexU, has ADP-ribosyl-
transferase and Rho–GAP activities (Sha et al., 2007; Sierra
et al., 2007, 2010). Overall, A. hydrophila SSU has
developed multiple mechanisms to circumvent innate
immunity in order to establish an infection, and the role
for each of these mechanisms in the disease process may
depend on the host environment as well as the stage of
infection.
In summary, Hcp binds to macrophages and induces the
production of immunosuppressive cytokines IL-10 and
TGF-b which results in impaired recruitment and inhibi-
tion of phagocytosis. This is the first report, to our
Fig. 6. rHcp induces an alternative pathway of macrophage
activation in the peritoneal lavages of mice infected with 310
7
c.f.u. A. hydrophila SSU Dact/DvasH mutant in the presence of
different doses of rHcp (1 and 10 mg), as determined by cytokine/
chemokine profiling. Cytokines were measured by multiplex bead
array on samples of intraperitoneal cavity lavages 4 h after
infection. Statistically significant differences were measured by
the one-way ANOVA test, followed by Tukey’s test. *P,0.05;
**P,0.01; ***P,0.001. Error bars indicate SD.
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modulates the activation of macrophages to cause systemic
infection in a mouse model. We focused our study on only
one isolate of A. hydrophila. Whether other species of
Aeromonas harbouring the T6SS behave similarly needs to
be further elucidated.
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